Nature Communications (Dec 2023)

Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses

  • Chuanyuan Wei,
  • Wei Sun,
  • Kangjie Shen,
  • Jingqin Zhong,
  • Wanlin Liu,
  • Zixu Gao,
  • Yu Xu,
  • Lu Wang,
  • Tu Hu,
  • Ming Ren,
  • Yinlam Li,
  • Yu Zhu,
  • Shaoluan Zheng,
  • Ming Zhu,
  • Rongkui Luo,
  • Yanwen Yang,
  • Yingyong Hou,
  • Fazhi Qi,
  • Yuhong Zhou,
  • Yong Chen,
  • Jianying Gu

DOI
https://doi.org/10.1038/s41467-023-43980-y
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Acral melanoma (AM) is a rare subtype of melanoma characterized by a high incidence of lymph node (LN) metastasis, a critical factor in tumor dissemination and therapeutic decision-making. Here, we employ single-cell and spatial transcriptomic analyses to investigate the dynamic evolution of early AM dissemination. Our findings reveal substantial inter- and intra-tumor heterogeneity in AM, alongside a highly immunosuppressive tumor microenvironment and complex intercellular communication networks, particularly in patients with LN metastasis. Notably, we identify a strong association between MYC + Melanoma (MYC +MEL) and FGFBP2 +NKT cells with LN metastasis. Furthermore, we demonstrate that LN metastasis requires a metabolic shift towards fatty acid oxidation (FAO) induced by MITF in MYC +MEL cells. Etomoxir, a clinically approved FAO inhibitor, can effectively suppress MITF-mediated LN metastasis. This comprehensive dataset enhances our understanding of LN metastasis in AM, and provides insights into the potential therapeutic targeting for the management of early AM dissemination.